Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Follow-On Field Study to Evaluate the Continued Efficacy and Safety of Ragweed-SPIRE Treatment in Ragweed Allergic Subjects Approximately One Year After the Completion of Treatment

NCT02396680 is registered in ClinicalTrials.gov with Circassia Limited as lead sponsor.

NCT NCT02396680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02396680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Follow-On Field Study to Evaluate the Continued Efficacy and Safety of Ragweed-SPIRE Treatment in Ragweed Allergic Subjects Approximately One Year After the Completion of Treatment
Lead sponsor
Circassia Limited
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
Not reported
Enrollment
249 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ragweed allergy, rhinoconjunctivitis